Dutch Bros (NYSE: BROS) has recently received a number of price target changes and ratings updates: 10/30/2026 – Dutch Bros had its price target lowered by Mizuho from $80.00 to $65.00. They now have an “outperform” rating on the stock. 10/26/2026 – Dutch Bros had its price target lowered by UBS Group from $85.00 to […]

Several brokerages have updated their recommendations and price targets on shares of AppLovin (NASDAQ: APP) in the last few weeks: 10/28/2026 – AppLovin had its price target lowered by UBS Group from $790.00 to $414.00. They now have a “buy” rating on the stock. 10/28/2026 – AppLovin had its price target lowered by Royal Bank […]

Several brokerages have updated their recommendations and price targets on shares of Schrodinger (NASDAQ: SDGR) in the last few weeks: 10/20/2026 – Schrodinger had its price target raised by UBS Group from $19.00 to $21.00. They now have a “neutral” rating on the stock. 10/16/2026 – Schrodinger had its price target raised by KeyCorp from […]

Several analysts have recently updated their ratings and price targets for Everpure (NYSE: P): 10/19/2026 – Everpure was upgraded by Zacks Research from “hold” to “strong-buy”. 10/14/2026 – Everpure was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”. 10/12/2026 – Everpure had its “neutral” rating reaffirmed by Cantor Fitzgerald. 10/12/2026 – Everpure had […]

GE Vernova (NYSE: GEV) recently received a number of ratings updates from brokerages and research firms: 11/2/2026 – GE Vernova had its price target lowered by Guggenheim from $1,450.00 to $1,400.00. They now have a “buy” rating on the stock. 10/30/2026 – GE Vernova had its price target raised by Glj Research from $470.00 to […]

Several analysts have recently updated their ratings and price targets for UMB Financial (NASDAQ: UMBF): 10/29/2026 – UMB Financial had its price target raised by TD Cowen from $152.00 to $154.00. They now have a “buy” rating on the stock. 10/29/2026 – UMB Financial had its price target lowered by Piper Sandler from $181.00 to […]

A number of research firms have changed their ratings and price targets for Centrus Energy (NYSE: LEU): 10/28/2026 – Centrus Energy had its price target lowered by B. Riley Financial from $295.00 to $188.00. They now have a “buy” rating on the stock. 10/27/2026 – Centrus Energy was given a new $151.00 price target by […]

Several brokerages have updated their recommendations and price targets on shares of CommVault Systems (NASDAQ: CVLT) in the last few weeks: 10/28/2026 – CommVault Systems had its price target raised by DA Davidson from $185.00 to $210.00. They now have a “buy” rating on the stock. 10/28/2026 – CommVault Systems had its price target raised […]

A number of research firms have changed their ratings and price targets for DuPont de Nemours (NYSE: DD): 10/30/2026 – DuPont de Nemours had its “sell (d+)” rating reaffirmed by Weiss Ratings. 10/15/2026 – DuPont de Nemours had its price target lowered by Royal Bank Of Canada from $176.00 to $160.00. They now have an […]

Several brokerages have updated their recommendations and price targets on shares of PTC Therapeutics (NASDAQ: PTCT) in the last few weeks: 11/2/2026 – PTC Therapeutics had its price target raised by Citigroup from $108.00 to $109.00. They now have a “buy” rating on the stock. 10/31/2026 – PTC Therapeutics was downgraded by Wall Street Zen […]

AngloGold Ashanti (NYSE: AU) has recently received a number of price target changes and ratings updates: 11/2/2026 – AngloGold Ashanti is now covered by TD Cowen. They set a “buy” rating and a $123.00 price target on the stock. 10/30/2026 – AngloGold Ashanti had its price target lowered by JPMorgan Chase & Co. from $139.00 […]

Flagstar Bank, National Association (NYSE: FLG) recently received a number of ratings updates from brokerages and research firms: 10/27/2026 – Flagstar Bank, National Association was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”. 10/27/2026 – Flagstar Bank, National Association had its price target lowered by UBS Group from $15.50 to $14.50. They now […]

Several analysts have recently updated their ratings and price targets for Tango Therapeutics (NASDAQ: TNGX): 10/29/2026 – Tango Therapeutics had its “buy” rating reaffirmed by HC Wainwright. They now have a $68.00 price target on the stock. 10/27/2026 – Tango Therapeutics was downgraded by Zacks Research from “hold” to “strong sell”. 10/23/2026 – Tango Therapeutics […]